EBR Systems (EBRCZ) Return on Sales (2025 - 2026)

EBR Systems' (EBRCZ) quarterly Return on Sales came in at 0.07% in Q1 2026, up 51.88% quarter-over-quarter from 0.15% in Q4 2025.

EBR Systems (EBRCZ) Return on Sales (2025 - 2026) Analysis & Trends

EBR Systems has disclosed Return on Sales across 2 years of filings, most recently posting 0.07% for Q1 2026.

Return on Sales for Q1 2026 came in at 0.07%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 0.14% (changed N/A YoY), and the FY2025 annual result was 0.3%, changed N/A from the prior year.
Return on Sales came in at 0.07% for Q1 2026 at EBR Systems, up from 0.15% in the prior quarter.
In the past five years, Return on Sales ranged from a high of 0.07% in Q1 2026 to a low of 0.71% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	0.00%
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	0.00%
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	0.00%
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	0.00%
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	0.00%
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.00%
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	0.00%
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	0.00%
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	EBR Systems	-	-	184,000.00	-0.07%

Download Data